Calcium Dynamics in Interstitial Cells of Cajal
Cajal 间质细胞中的钙动态
基本信息
- 批准号:7120528
- 负责人:
- 金额:$ 26.19万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2000
- 资助国家:美国
- 起止时间:2000-04-01 至 2010-06-30
- 项目状态:已结题
- 来源:
- 关键词:action potentialscalcium channelcell proliferationclinical researchelectroporationgastrointestinal motility /pressurehuman tissueimmunocytochemistrylaboratory mouselaser capture microdissectionmyenteric plexusorgan culturepolymerase chain reactionserotoninserotonin receptortissue /cell culturevoltage /patch clampwestern blottings
项目摘要
DESCRIPTION (provided by applicant): The overall objective of this proposal is to define the mechanisms that control survival, proliferation and loss of interstitial cells of Cajal (ICC). Normal gastrointestinal motility requires intact networks of ICC. Loss of ICC is associated with several disorders of gastrointestinal motility. Despite the prominent role ICC play in the control of gastrointestinal motility, the mechanisms that regulate their survival and proliferation and loss are still largely unknown. Maintenance of ICC numbers requires a balance between survival and proliferation and loss. The overarching theme of our work is that 5HT, through specific 5HT receptors expressed on ICC, regulates the balance between survival and proliferation of ICC and loss of ICC. The PI will test this central hypothesis by the use of primary cultures and organotypic cultures of ICC, patch clamp techniques on freshly dissociated human ICC and cultured mouse ICC, muscle strips to simultaneously record mechanical activity and intracellular electrical activity from ICC, immunohistochemistry, Ca2+ imaging, laser capture microdissection, electroporation, Western blots, RT-PCR, single cell PCR, and quantitative PCR. To determine the role of 5HT in the regulation of survival, proliferation and loss of ICC three hypotheses will be tested: 1) 5HT increases the number of ICC; 2) 5HT1, 5HT2B, 5HT3 and 5HT7 receptors are expressed on ICC; and 3) 5HT regulates cell survival, proliferation and loss by activation of specific 5HT receptors expressed on ICC that modulate intracellular Ca2+ handling. These hypotheses are supported by preliminary data that show that 5HT markedly increases ICC number in cellular and organotypic cultures, that ICC proliferate, that ICC express death receptors and undergo apoptosis, a necessary physiological process to regulate tissue homeostasis, that specific 5HT receptors are expressed on human and mouse ICC and that 5HT regulates intracellular Ca2+ in ICC. Successful completion of the proposed studies has both basic significance and clinical impact. The results of the studies will lead to a better understanding of the basic mechanisms that regulate the number of ICC while at the same time provide a better understanding of the mechanisms that contribute to loss of ICC and the development of motility disorders associated with ICC loss. Indeed, based on our preliminary data, early, directed, 5HT-based treatment may be proposed as a mechanism to reverse loss of ICC in motility disorders.
描述(由申请人提供):本提案的总体目标是确定控制Cajal (ICC)间质细胞存活、增殖和丧失的机制。正常的胃肠运动需要完整的ICC网络。ICC的丧失与几种胃肠运动障碍有关。尽管ICC在胃肠道运动的控制中发挥着重要作用,但调节其存活、增殖和丧失的机制仍在很大程度上是未知的。维持ICC数量需要在存活、增殖和损失之间取得平衡。我们工作的首要主题是5HT,通过在ICC上表达的特定5HT受体,调节ICC存活和增殖与ICC丧失之间的平衡。PI将通过使用ICC的原代培养和器官型培养,对新分离的人ICC和培养的小鼠ICC进行膜片钳技术,同时记录ICC机械活动和细胞内电活动的肌肉条,免疫组织化学,Ca2+成像,激光捕获显微解剖,电穿孔,Western blots, RT-PCR,单细胞PCR和定量PCR来验证这一中心假设。为了确定5HT对ICC存活、增殖和丧失的调控作用,我们将检验三个假设:1)5HT增加ICC的数量;2) 5HT1、5HT2B、5HT3、5HT7受体在ICC上表达;3) 5HT通过激活ICC上表达的特定5HT受体来调节细胞内Ca2+处理,从而调节细胞的存活、增殖和损失。这些假设得到了初步数据的支持,这些数据表明5HT显著增加细胞和器官型培养中的ICC数量,ICC增殖,ICC表达死亡受体并经历凋亡,这是调节组织稳态的必要生理过程,特异性5HT受体在人和小鼠ICC上表达,5HT调节ICC细胞内Ca2+。本研究的成功完成既有基础意义又有临床意义。这些研究的结果将有助于更好地了解调节ICC数量的基本机制,同时也有助于更好地了解导致ICC丧失和与ICC丧失相关的运动障碍发展的机制。事实上,根据我们的初步数据,早期的、定向的、基于5ht的治疗可能被提议作为一种机制来逆转运动障碍中ICC的丧失。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
GIANRICO FARRUGIA其他文献
GIANRICO FARRUGIA的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('GIANRICO FARRUGIA', 18)}}的其他基金
CALCIUM DYNAMICS IN INTERSTITIAL CELLS OF CAJAL
CAJAL 间质细胞中的钙动力学
- 批准号:
6381720 - 财政年份:2000
- 资助金额:
$ 26.19万 - 项目类别:
Calcium Dynamics in Interstitial Cells of Cajal
Cajal 间质细胞中的钙动态
- 批准号:
8290442 - 财政年份:2000
- 资助金额:
$ 26.19万 - 项目类别:
CALCIUM DYNAMICS IN INTERSTITIAL CELLS OF CAJAL
CAJAL 间质细胞中的钙动力学
- 批准号:
6727510 - 财政年份:2000
- 资助金额:
$ 26.19万 - 项目类别:
Calcium Dynamics in Interstitial Cells of Cajal
Cajal 间质细胞中的钙动态
- 批准号:
10425251 - 财政年份:2000
- 资助金额:
$ 26.19万 - 项目类别:
Calcium Dynamics in Interstitial Cells of Cajal
Cajal 间质细胞中的钙动态
- 批准号:
7643917 - 财政年份:2000
- 资助金额:
$ 26.19万 - 项目类别:
相似海外基金
L-type Calcium Channel SNP rs1006737: characterizing the genetic risks in MUD (Methamphetamine Use Disorder)
L 型钙通道 SNP rs1006737:表征 MUD(甲基苯丙胺使用障碍)的遗传风险
- 批准号:
10668210 - 财政年份:2023
- 资助金额:
$ 26.19万 - 项目类别:
Development of a Novel Calcium Channel Therapeutic for the Treatment of Asthma
开发治疗哮喘的新型钙通道疗法
- 批准号:
10603554 - 财政年份:2023
- 资助金额:
$ 26.19万 - 项目类别:
Development of a Novel Calcium Channel Therapeutic for Opioid Use Disorder
开发一种治疗阿片类药物使用障碍的新型钙通道疗法
- 批准号:
10684558 - 财政年份:2023
- 资助金额:
$ 26.19万 - 项目类别:
Development of a Novel Medication for Alcohol Use Disorder with an Active IND Dual Inhibitor of T-Type Calcium Channel and Soluble Epoxide Hydrolase
使用 T 型钙通道和可溶性环氧化物水解酶的活性 IND 双重抑制剂开发治疗酒精使用障碍的新型药物
- 批准号:
10815882 - 财政年份:2023
- 资助金额:
$ 26.19万 - 项目类别:
Novel Tools to Probe Trafficking and Function of Calcium Channel Signaling Complexes in Heart
探测心脏钙通道信号复合物的运输和功能的新工具
- 批准号:
10628914 - 财政年份:2023
- 资助金额:
$ 26.19万 - 项目类别:
Mechanisms of L-type Calcium Channel Regulation in Heart Health and Disease
L 型钙通道在心脏健康和疾病中的调节机制
- 批准号:
10734121 - 财政年份:2023
- 资助金额:
$ 26.19万 - 项目类别:
Structure-Function of Calcium Channel Complexes in Cardiac Physiology and Disease
钙通道复合物在心脏生理和疾病中的结构-功能
- 批准号:
10628911 - 财政年份:2023
- 资助金额:
$ 26.19万 - 项目类别:
Research Initiation Award: Defining the role of DJ-1 in regulating L-type voltage-dependent calcium channel expression in neuronal plasticity
研究启动奖:定义 DJ-1 在调节神经元可塑性中 L 型电压依赖性钙通道表达中的作用
- 批准号:
2200474 - 财政年份:2022
- 资助金额:
$ 26.19万 - 项目类别:
Standard Grant
Design and Preclinical Development of First-in-Class Selective T-type Calcium Channel Blockers for Chronic Pain
用于治疗慢性疼痛的一流选择性 T 型钙通道阻滞剂的设计和临床前开发
- 批准号:
452107 - 财政年份:2021
- 资助金额:
$ 26.19万 - 项目类别:
Operating Grants
Preventing the Calcium Channel Blocker – Lower Extremity Edema – Loop Diuretic Prescribing Cascade in Older Adults
预防钙通道阻滞剂 – 下肢水肿 – 老年人袢利尿剂处方级联
- 批准号:
10399417 - 财政年份:2021
- 资助金额:
$ 26.19万 - 项目类别: